136 related articles for article (PubMed ID: 38493204)
1. Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma.
Nejo T; Wang L; Leung KK; Wang A; Lakshmanachetty S; Gallus M; Kwok DW; Hong C; Chen LH; Carrera DA; Zhang MY; Stevers NO; Maldonado GC; Yamamichi A; Watchmaker PB; Naik A; Shai A; Phillips JJ; Chang SM; Wiita AP; Wells JA; Costello JF; Diaz AA; Okada H
Sci Rep; 2024 Mar; 14(1):6362. PubMed ID: 38493204
[TBL] [Abstract][Full Text] [Related]
2. Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma.
Nejo T; Wang L; Leung KK; Wang A; Lakshmanachetty S; Gallus M; Kwok DW; Hong C; Chen LH; Carrera DA; Zhang MY; Stevers NO; Maldonado GC; Yamamichi A; Watchmaker P; Naik A; Shai A; Phillips JJ; Chang SM; Wiita AP; Wells JA; Costello JF; Diaz AA; Okada H
bioRxiv; 2023 Nov; ():. PubMed ID: 37961484
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients.
Kahles A; Lehmann KV; Toussaint NC; Hüser M; Stark SG; Sachsenberg T; Stegle O; Kohlbacher O; Sander C; ; Rätsch G
Cancer Cell; 2018 Aug; 34(2):211-224.e6. PubMed ID: 30078747
[TBL] [Abstract][Full Text] [Related]
4. Computer Analysis of Glioma Transcriptome Profiling: Alternative Splicing Events.
Babenko VN; Gubanova NV; Bragin AO; Chadaeva IV; Vasiliev GV; Medvedeva IV; Gaytan AS; Krivoshapkin AL; Orlov YL
J Integr Bioinform; 2017 Sep; 14(3):. PubMed ID: 28918420
[TBL] [Abstract][Full Text] [Related]
5. Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common
Lim WC; Marques Da Costa ME; Godefroy K; Jacquet E; Gragert L; Rondof W; Marchais A; Nhiri N; Dalfovo D; Viard M; Labaied N; Khan AM; Dessen P; Romanel A; Pasqualini C; Schleiermacher G; Carrington M; Zitvogel L; Scoazec JY; Geoerger B; Salmon J
Front Immunol; 2023; 14():1265469. PubMed ID: 38318504
[TBL] [Abstract][Full Text] [Related]
6. IRIS: Discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing.
Pan Y; Phillips JW; Zhang BD; Noguchi M; Kutschera E; McLaughlin J; Nesterenko PA; Mao Z; Bangayan NJ; Wang R; Tran W; Yang HT; Wang Y; Xu Y; Obusan MB; Cheng D; Lee AH; Kadash-Edmondson KE; Champhekar A; Puig-Saus C; Ribas A; Prins RM; Seet CS; Crooks GM; Witte ON; Xing Y
Proc Natl Acad Sci U S A; 2023 May; 120(21):e2221116120. PubMed ID: 37192158
[TBL] [Abstract][Full Text] [Related]
7. Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arrays.
Cheung HC; Baggerly KA; Tsavachidis S; Bachinski LL; Neubauer VL; Nixon TJ; Aldape KD; Cote GJ; Krahe R
BMC Genomics; 2008 May; 9():216. PubMed ID: 18474104
[TBL] [Abstract][Full Text] [Related]
8. Identification of HLA a*0201 glioblastoma multiforme cell lines for immunotherapy by PCR-SSP and DNA sequencing.
Wu AH; Hall WA; Low WC
J Neurooncol; 2004 Jan; 66(1-2):1-8. PubMed ID: 15015764
[TBL] [Abstract][Full Text] [Related]
9. Spatial organization of heterogeneous immunotherapy target antigen expression in high-grade glioma.
Barish ME; Weng L; Awabdeh D; Zhai Y; Starr R; D'Apuzzo M; Rockne RC; Li H; Badie B; Forman SJ; Brown CE
Neoplasia; 2022 Aug; 30():100801. PubMed ID: 35550513
[TBL] [Abstract][Full Text] [Related]
10. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
[TBL] [Abstract][Full Text] [Related]
11. Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapy.
Li G; Mahajan S; Ma S; Jeffery ED; Zhang X; Bhattacharjee A; Venkatasubramanian M; Weirauch MT; Miraldi ER; Grimes HL; Sheynkman GM; Tilburgs T; Salomonis N
Sci Transl Med; 2024 Jan; 16(730):eade2886. PubMed ID: 38232136
[TBL] [Abstract][Full Text] [Related]
12. Tumor antigens in glioma.
Nejo T; Yamamichi A; Almeida ND; Goretsky YE; Okada H
Semin Immunol; 2020 Feb; 47():101385. PubMed ID: 32037183
[TBL] [Abstract][Full Text] [Related]
13. Classification of glioma based on prognostic alternative splicing.
Li Y; Ren Z; Peng Y; Li K; Wang X; Huang G; Qi S; Liu Y
BMC Med Genomics; 2019 Nov; 12(1):165. PubMed ID: 31729991
[TBL] [Abstract][Full Text] [Related]
14. Developmental isoform diversity in the human neocortex informs neuropsychiatric risk mechanisms.
Patowary A; Zhang P; Jops C; Vuong CK; Ge X; Hou K; Kim M; Gong N; Margolis M; Vo D; Wang X; Liu C; Pasaniuc B; Li JJ; Gandal MJ; de la Torre-Ubieta L
bioRxiv; 2023 Oct; ():. PubMed ID: 36993726
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide analyses of the prognosis-related mRNA alternative splicing landscape and novel splicing factors based on large-scale low grade glioma cohort.
Liu WR; Li CY; Xu WH; Liu XJ; Tang HD; Huang HN
Aging (Albany NY); 2020 Jul; 12(13):13684-13700. PubMed ID: 32658870
[TBL] [Abstract][Full Text] [Related]
16. Single-cell RNA sequencing reveals functional heterogeneity of glioma-associated brain macrophages.
Ochocka N; Segit P; Walentynowicz KA; Wojnicki K; Cyranowski S; Swatler J; Mieczkowski J; Kaminska B
Nat Commun; 2021 Feb; 12(1):1151. PubMed ID: 33608526
[TBL] [Abstract][Full Text] [Related]
17. An unexplored angle: T cell antigen discoveries reveal a marginal contribution of proteasome splicing to the immunogenic MHC class I antigen pool.
Verkerk T; Koomen SJI; Fuchs KJ; Griffioen M; Spaapen RM
Proc Natl Acad Sci U S A; 2022 Jul; 119(29):e2119736119. PubMed ID: 35858315
[TBL] [Abstract][Full Text] [Related]
18. Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy.
Neidert MC; Schoor O; Trautwein C; Trautwein N; Christ L; Melms A; Honegger J; Rammensee HG; Herold-Mende C; Dietrich PY; Stevanović S
J Neurooncol; 2013 Feb; 111(3):285-94. PubMed ID: 23263746
[TBL] [Abstract][Full Text] [Related]
19. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
20.
Zhang Z; Zhou C; Tang L; Gong Y; Wei Z; Zhang G; Wang F; Liu Q; Yu J
Aging (Albany NY); 2020 Jul; 12(14):14633-14648. PubMed ID: 32697765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
